Skip to content

Evaluation of pelvic and abdominal cavity single-port endoscopic technique in the treatment of benign diseases: a non randomized controlled single center clinical study

Evaluation of pelvic and abdominal cavity single-port endoscopic technique in the treatment of benign diseases: a non randomized controlled single center clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035280
Enrollment
Unknown
Registered
2020-08-06
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic and abdominal cavity of benign diseases

Interventions

Single-port group:Nil
CLS group:Nil

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with benign pelvic and abdominal diseases (including ovarian cyst, hysteromyoma, ectopic pregnancy, abdominal wall hernia, gallstone, cholecystitis); 2. Age: minimum age > 18 years old, maximum age = 60; 5. First treatment; 6. The subjects volunteered to join the study, signed the informed consent form, had good compliance and cooperated with the follow-up.

Exclusion criteria

Exclusion criteria: 1. All kinds of contraindications of operation can not accept operation; 2. CT, MRI or pet showed the possibility of malignant tumor and potential metastasis.

Design outcomes

Primary

MeasureTime frame
VAS score;VAS score;In-charge days;

Secondary

MeasureTime frame
Bleeding;Fee;

Countries

China

Contacts

Public ContactBao Wei

?????????

forever_chipper@hotmail.com+86 13361817336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026